Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma.
暂无分享，去创建一个
M. Fakih | Y. Rustum | A. Rajput | C. LeVea | L. Pendyala | Young-Mee Park | K. Toth | Gary Y. Yang | A. Puthillath | C. Andrews | M. E. Ross | K. Bullarddunn